NEUROTOL G-VIT VITACAL XTRA EPLACHERRYS COMPOUND FEMOCAL PLUS CAL-V-CON MULTICAL-PLUS FERRODIN-F FERRODIN OSSO PLUS TONUM TONUM VIOPHOS-B MINOLAD DIADYNAM-G PREGNA CARE NUTRITION-6 NUTRITION-12 HIGH-C PLUS EFER-VIT ENERGIN AWARDIN AWARDIN AWARDIN PLUS AMVIT AMVIT MB-TONE FORTE MB-FORTE MB-FORTE POLY CAL PLUS K-CEE PLUS CALCEPLEX FORTE CALVIT PLUS

Calcium Glycerophosphate also known as Calcium Glycerinophosphate. . It is of Synthetic origin and belongs to Calcium salt. . The Molecular Weight of Calcium Glycerophosphate is 210.10.

Calcium Glycerophosphate is contraindicated in conditions like Hypercalcaemia,Renal calculi.

The severe or irreversible adverse effects of Calcium Glycerophosphate, which give rise to further complications include Hypotension, Hypercalcemia, Sinus bradycardia.Calcium Glycerophosphate produces potentially life-threatening effects which include Coma, Cardiac Arrest. which are responsible for the discontinuation of Calcium Glycerophosphate therapy.The symptomatic adverse reactions produced by Calcium Glycerophosphate are more or less tolerable and if they become severe, they can be treated symptomatically, these include Nausea, Vomiting, Constipation, Abdominal pain, Local reactions, Polyuria, Muscle weakness, Syncope, GI irritation.

Calcium Glycerophosphate is primarily indicated in conditions like Calcium deficiency state, Hypocalcaemia, Osteoporosis prophylaxis, and can also be given in adjunctive therapy as an alternative drug of choice in Cardiopulmonary resuscitation, Severe hyperkalaemia, Severe hypermagnesaemia.

No data regarding the interactions of Calcium Glycerophosphate was found.

Drug should not be given to Paediatrics, Pregnant Mothers, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Syrups,tabs,caps,powder Store in a well closed container, .

Calcium glycerophosphate should be used with caution in patients with impaired renal function, pre-existing cardiac arrhythmias, dehydration, diarrhoea, malabsorption or diseases associated with elevated vitamin D concentrations such as sarcoidosis. Generally calcium salts should be avoided in patients with calcium renal calculi. Plasma-calcium concentrations should be monitored closely in patients with renal insufficiency and during parentral administration and if large doses of vitamin D are used.